Taoka Chemical Company, Limited

TSE:4113.T

898 (JPY) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 28,544.44930,166.52132,374.01732,057.44325,671.60124,457.57221,843.79721,000.82420,916.70119,779.80217,920.917,206.52117,305.28117,541.13614,800.54217,148.79817,977.275
Cost of Revenue 23,966.22926,166.22426,052.52424,840.13420,002.37718,849.03116,842.42516,382.6616,391.15516,143.99314,861.514,202.90114,302.10214,238.25411,933.58814,565.72414,981.286
Gross Profit 4,578.224,000.2976,321.4937,217.3095,669.2245,608.5415,001.3724,618.1644,525.5463,635.8093,059.43,003.623,003.1793,302.8822,866.9542,583.0742,995.989
Gross Profit Ratio 0.160.1330.1950.2250.2210.2290.2290.220.2160.1840.1710.1750.1740.1880.1940.1510.167
Reseach & Development Expenses 858.804837907783714797719.483711.607696.706685674533.167479.496469.048407.767416.942431.703
General & Administrative Expenses 1,9532,0001,9831,7491,5991,6491,635.3861,530.8211,487.2861,4521,349515.043549.918524.055494.505490.23555.486
Selling & Marketing Expenses 69271272366966761257156753152850246700000
SG&A 2,644.4552,7122,7062,4182,2662,2612,206.3862,097.8212,018.2861,9801,851515.043549.918524.055494.505490.23555.486
Other Expenses 27.7049.61853.91616.28213.58911.32412.86728.95417.91831.94143.06730.89513.927-8.565-11.84238.396-14.289
Operating Expenses 3,503.2593,549.2413,613.1583,201.7862,980.2463,058.3682,925.8692,809.4282,714.9912,665.4792,525.1531,938.5661,873.5771,822.0831,747.6531,754.9931,649.279
Operating Income 1,074.961451.0552,708.3334,015.5222,688.9772,550.1722,075.5011,808.7351,810.554970.329534.245576.282642.075904.356550.686191.351633.655
Operating Income Ratio 0.0380.0150.0840.1250.1050.1040.0950.0860.0870.0490.030.0330.0370.0520.0370.0110.035
Total Other Income Expenses Net 53.0532659-3545-34-128.338-47.238-97.846-383.321-100.965-1,216.219-741.817-689.781331.779-1,591.224-940.163
Income Before Tax 1,128.014478.1682,768.7613,662.5482,694.5132,517.4111,947.1641,761.4981,712.709587.009433.282-151.165387.785791.0181,451.08-763.143406.547
Income Before Tax Ratio 0.040.0160.0860.1140.1050.1030.0890.0840.0820.030.024-0.0090.0220.0450.098-0.0450.023
Income Tax Expense 307.534167.516705.0241,047.14797.02697.753583.676498.856602.151263.148196.635-169.202231.711294.16595.789-279.872183.959
Net Income 820.48310.652,063.7362,615.4071,897.4941,819.6581,363.4881,262.6421,110.558323.861236.64718.037156.074496.857855.291-483.27222.588
Net Income Ratio 0.0290.010.0640.0820.0740.0740.0620.060.0530.0160.0130.0010.0090.0280.058-0.0280.012
EPS 57.2621.68144.04182.58132.41126.9895.1288.0477.4122.5716.491.2610.8734.659.54-33.6415.48
EPS Diluted 57.2621.68144.04182.58132.41126.9895.1288.0477.4122.5716.491.2610.8734.659.54-33.6415.48
EBITDA 2,539.4991,909.1414,258.7185,546.2454,155.0073,947.3073,395.0622,863.3412,866.5652,124.6991,605.4412,015.2521,971.7262,792.0712,425.8522,231.1192,600.69
EBITDA Ratio 0.0890.0630.1320.1730.1620.1610.1550.1360.1370.1070.090.1170.1140.1590.1640.130.145